3 unstoppable ASX shares to buy with $3,000

These investments have a very exciting future!

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The ASX share market regularly goes through volatility, any share price can go down. But there are a few names that I reckon can deliver market-beating returns, aren't overpriced and could be less volatile than the wider local or global share market.

I'm going to talk about three of my favourite long-term ideas, each offering a very different investment exposure.

There are three investments I want to tell you about – an exchange-traded fund (ETF), an ASX share and a listed investment company (LIC). I'd call them all 'unstoppable' investments and I'd love to invest $3,000 in them.

Five arrows hit the bullseye of five round targets lined up in a row, with a blue sky in the background.

Image source: Getty Images

VanEck Morningstar Wide Moat ETF (ASX: MOAT)

The MOAT ETF is an excellent long-term investment option because of the types of businesses it invests in.

It invests in high-quality US-listed businesses that are seen by Morningstar as having wide economic moats. In other words, competitive advantages that are so strong and enduring that analysts think they could last for the next 20 years.

If the business is able to stay ahead of competitors for that long, it could generate pleasing profit growth for many years to come.

By only investing in these wide moat businesses, investors have a great chance at experiencing long-term returns. Competitive advantages could include things like cost advantages, network effects, patents and so on.

The MOAT ETF only invests in these great businesses when they're trading at a good value price. Therefore, it's a portfolio of great companies at attractive prices.

Over the past ten years, it has returned an average of around 14%.

Sigma Healthcare Ltd (ASX: SIG)

Sigma Healthcare is a leading ASX share in the healthcare space because of its Chemist Warehouse business and its wholesale pharmacy distribution.

Healthcare is a strong long-term growth sector with Australia's ageing and growing long-term population, giving it an earnings tailwind.

With Chemist Warehouse growing total network sales in the double-digits year-over-year, it's clearly got a very exciting future with both strong like-for-like sales growth at the existing locations and adding more locations in Australia and overseas.

Chemist Warehouse is already in New Zealand, Ireland, Dubai and China, with the company recently announcing it's entering the UK market too.

As its scale becomes larger, its profit margins can rise thanks to operating leverage.

I think it could become a significantly larger business if it gets its northern-hemisphere expansion right.

L1 Long Short Fund Ltd (ASX: LSF)

This ASX share is a listed investment company (LIC) that invests in both ASX shares and global shares to find the best opportunities.

It looks across different sectors for opportunities, though it doesn't rely on tech for its investment strategy. It generally looks at businesses with a low price/earnings (P/E) ratio and good earnings growth potential. In other words, businesses that are undervalued.

By investing in undervalued businesses and cyclical names during a weak part in the cycle, the business can deliver great outperformance when the team is right.  

L1 Long Short Fund's portfolio has returned an average of 16.3% per year over the past five years, which is an excellent level of performance and helps it deliver both capital growth and dividends. Past performance is not a guarantee of future returns, though.

Motley Fool contributor Tristan Harrison has positions in L1 Long Short Fund and VanEck Morningstar Wide Moat ETF. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended VanEck Morningstar Wide Moat ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

Rocket takes off from the hand of a businessman.
IPOs

What's gone wrong with the SpaceX IPO?

SpaceX rocketed on the IPO, but its flight path has since stalled.

Read more »

A female athlete in green spandex leaps from one cliff edge to another.
Opinions

A rare buying opportunity in 1 of Australia's top shares?

This stock could provide delicious returns.

Read more »

A graphic depicting a businessman in a business suit standing with his hand to his chin looking at a large red arrow pointing upwards above a line up of oil barrels againist the backdrop of a world map.
Energy Shares

With Hormuz closed, is there an opening to buy Woodside shares?

Should investors react to this news out of the Middle East?

Read more »

Three trophies in declining sizes with a red curtain backdrop.
Opinions

3 ASX shares I'd buy with $5,000 this week

These ASX shares are tipped to increase 20% or more over the next 12 months.

Read more »

A young investor working on his ASX shares portfolio on his laptop.
Opinions

2 ASX LICs to buy now: expert

LICs typically invest in diversified asset portfolios and are traded like ordinary ASX shares.

Read more »

A gold gloved hand is held up in a stop gesture.
Opinions

Up 80% in 2 years with a 15% dividend yield, expert says sell this ASX ETF now

Let's take a look.

Read more »

A group of young people lined up on a wall are happy looking at their laptops and devices as they invest in the latest trendy stock.
Opinions

Could July give the ASX 200 the push it needs after a quiet finish to June?

History suggests July could be worth watching for our local shares.

Read more »

Five young boys wearing small caps sit on a bench together watching a baseball game.
Opinions

5 ASX 200 shares I'd buy with $5,000 in July

I think these ASX 200 shares are now trading below fair value.

Read more »